| Product NDC: | 10237-741 |
| Proprietary Name: | Orajel for Cold Sores |
| Non Proprietary Name: | Benzalkonium Chloride, Benzocaine |
| Active Ingredient(s): | .13; .5 mg/mL; mg/mL & nbsp; Benzalkonium Chloride, Benzocaine |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10237-741 |
| Labeler Name: | Church & Dwight Co., Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part356 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120701 |
| Package NDC: | 10237-741-04 |
| Package Description: | 2 VIAL in 1 PACKAGE (10237-741-04) > .6 mL in 1 VIAL |
| NDC Code | 10237-741-04 |
| Proprietary Name | Orajel for Cold Sores |
| Package Description | 2 VIAL in 1 PACKAGE (10237-741-04) > .6 mL in 1 VIAL |
| Product NDC | 10237-741 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Benzalkonium Chloride, Benzocaine |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20120701 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Church & Dwight Co., Inc. |
| Substance Name | BENZALKONIUM CHLORIDE; BENZOCAINE |
| Strength Number | .13; .5 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes |